This page summarizes information about the clinical trials that support investigation of both approved and experimental medicines. This information includes information about the interventions and their sponsoring organizations. Note that these data are derived from ClinicalTrials.gov, with information corrected and disambiguated to convey more accurate detail about these trials. Phase 4 trials are currently excluded on this page by default, as this data will be analyzed separately at a later date.
Trials with Experimental APIs
Top 5 (by most trials)
bnt162b2 (96) mrna-1273 (71) tumor-pulsed dendritic cells (64) multi-valent pneumococcal conjugate vaccine (62) gp-100 peptide vaccine (58)Trials with Approved APIs
Top 5 (by most trials)
inactivated influenza vaccine (798) pneumococcal 13-valent conjugate vaccine (245) hepatitis b vaccine (recombinant) (215) bacille calmette-guerin (169) Meningococcal (Groups A, C, Y, W) Conjugate Vaccine (160)Trials with Unapproved APIs
Top 5 (by most trials)
typhoid vaccine (10)Phase 2 Sponsors
Top 5 (by most trials)
GlaxoSmithKline (255) National Cancer Institute (NCI) (216) National Institute of Allergy and Infectious Diseases (NIAID) (195) Sanofi (113) Novartis (100)Phase 3 Sponsors
Top 5 (by most trials)
GlaxoSmithKline (378) Merck (157) Sanofi (111) Government of China (109) Sanofi-Aventis (104)